GBUK Global

Globally Enhancing Patient Care

Elevating Patient Evacuations: A Pinnacle Journey with Advanced Techniques

Elevating Patient Evacuations: A Pinnacle Journey with Advanced Techniques 150 150 GBUK Marketing

In the field of patient care, prioritising a graceful and dignified evacuation process stands as a fundamental necessity.

Our team are dedicated to ensuring the well-being, safety, and dignity of our patients, employs state-of-the-art techniques and specialised equipment to orchestrate a seamless transition. Join us on this transformative journey as we shine a spotlight on innovative tools, such as the FloJac, Banana Slide Sheets, and Lateral Boards, that redefine the evacuation experience.

A Pioneering Approach to Risk Assessment: Every successful evacuation commences with an exhaustive risk assessment. Our team meticulously scrutinises potential challenges, tailoring the evacuation plan to suit the unique needs of each patient. This meticulous initial step lays the groundwork for a carefully coordinated and efficient process.

Cutting-Edge Techniques Unveiled: Taking centre stage in our evacuation procedures is the revolutionary FloJac—a device that redefines patient care. Its innovative design facilitates gentle and controlled movement, minimising discomfort and ensuring the utmost safety. This advanced technology transforms the evacuation experience, delivering a profound impact on both patients and caregivers alike.

Banana Slide Sheets: Redefining Comfort and Control: Our commitment to patient comfort is exemplified by the utilisation of Banana Slide Sheets. Specifically crafted, these sheets facilitate smooth and controlled movements, effectively reducing friction and enhancing the overall evacuation process. Playing a pivotal role in preserving dignity, Banana Slide Sheets ensure a positive experience for patients with diverse needs.

Lateral Boards for Precision Transitions: Precision is paramount during evacuations, and lateral boards emerge as indispensable tools for achieving seamless transitions. These boards assist in moving patients with care and accuracy, addressing the unique challenges presented by various evacuation scenarios. The proficiency of our team in utilising lateral boards guarantees that each patient undergoes a dignified and secure evacuation.

Patient-Centric Excellence: Throughout the evacuation process, our unwavering focus on the patient remains resolute. The use of specialised equipment aligns seamlessly with our commitment to providing personalised and compassionate care. Every action is guided by the principles of dignity, ensuring that each patient feels profoundly valued and supported during the entire evacuation journey.

From the systematic risk assessment to the final steps of a patient’s evacuation, our dedicated team employs cutting-edge techniques and specialised equipment to redefine the entire experience. The use of the FloJac, Banana Slide Sheets, and Lateral Boards underscores our unwavering commitment to ensuring patient comfort, safety, and dignity. As we navigate the intricacies of evacuations, the overarching goal remains crystal clear: to provide a seamless and dignified experience for every patient.

GBUK Group acquires Severn Healthcare Technologies

GBUK Group acquires Severn Healthcare Technologies 150 150 GBUK Marketing

GBUK Group, a portfolio company of A&M Capital Europe (“AMCE”), a London-based private equity firm with €650 million of commitments under management, has acquired UK-based Severn Healthcare Technologies (“Severn”), a value-added and fast-growing distributor of single-use medical devices.

Founded in 2014, Severn specialises in providing next-generation single-use medical devices across the Ear, Nose, and Throat (“ENT”) and Neuro-Otology clinical specialisms. Supporting the adoption of clinical innovation in operating theatres across the National Health Service (“NHS”) and the UK Private market, we believe Severn has built a reputation as a trusted partner to surgical clinicians on the foundations of deep technical expertise and exceeding customer service.

The acquisition of Severn represents GBUK’s second acquisition since AMCE’s investment in December 2023. The acquisition is expected to strengthen GBUK’s clinical specialist positioning further while expanding its product presence in two new and innovative therapeutic areas.

GBUK were advised by Rothschild & Co as financial adviser, Burness Paull as legal adviser, Accuracy as accounting adviser, and PMSI as commercial adviser.

About GBUK Group

Headquartered in the United Kingdom, GBUK Group designs develops and distributes a comprehensive portfolio of own and third-party branded acute-setting medical devices across enteral feeding, vascular access, patient handling and the broader critical care environment. The Company is a top 20 supplier to the UK NHS and supports healthcare professionals and patients in over 45 countries with more than 600,000 medical devices daily. GBUK Group has demonstrated a track record of penetrating new care areas by leveraging its R&D capabilities and a high-touch sales model hinged on wrap-around services. To find out more, visit www.gbukgroup.com.

About A&M Capital Europe

AMCE is a London-headquartered private equity investment firm specialising in building pan-European platform companies through buy-and-build and organic growth initiatives. AMCE Fund I currently has €650 million of commitments under management, and Severn represents AMCE’s twenty-third transaction across its eight portfolio companies. More broadly, AMCE is part of A&M Capital, a multi-strategy private equity investment firm that manages commitments totalling ~€5.5 billion across all its investment strategies. In addition, A&M Capital maintains a strategic association with Alvarez & Marsal, one of the world’s largest growth and operationally focused advisory firms. For additional information, please visit A&M Capital Europe’s website at www.a-mcapital.com.

GBUK Acquires Care & Independence

GBUK Acquires Care & Independence 150 150 GBUK Marketing

GBUK, a portfolio company of A&M Capital Europe (“AMCE”), a London-based private equity firm with €650 million of commitments under management, has acquired Care & Independence (“C&I”), a fast-growing UK provider of patient handling and moving devices.

Founded in 1985, C&I specialises in the provision of medical slings, bathing equipment and broader postural support devices. Within its core UK market, C&I is a preferred supplier to the National Health Service (“NHS”) and primarily serves the needs of patients within the community setting via loan store operators, independent local authorities, and NHS Trusts. Like GBUK, C&I operates a clinician-orientated high-touch sales model that supports Occupational Therapists with clinical product training and patient requirement assessments.

The acquisition of C&I represents GBUK’s first acquisition since AMCE’s investment in December 2023. The acquisition is expected to strengthen GBUK’s positioning within the UK patient handling market, providing further breadth to GBUK’s product offering and an established platform for growth within the community-setting.

AMCE and GBUK were advised by Burness Paull as legal adviser, Accuracy as accounting adviser, and EY as tax adviser.

About GBUK

Headquartered in the United Kingdom, GBUK designs, develops and distributes a comprehensive portfolio of own and third-party branded acute-setting medical devices across enteral feeding, vascular access, patient handling and the broader critical care environment. The Company is a top 20 supplier to the UK NHS and supports healthcare professionals and patients in over 45 countries with more than 600,000 medical devices daily. GBUK has demonstrated a track record of penetrating new care areas by leveraging its R&D capabilities and a high-touch sales model hinging on wrap-around services.

About A&M Capital Europe

AMCE is a London-headquartered private equity investment firm specialising in building pan-European platform companies through buy-and-build and organic growth initiatives. AMCE Fund I currently has €650 million of commitments under management, and C&I represents AMCE’s twenty-second transaction. More broadly, AMCE is part of A&M Capital, a multi-strategy private equity investment firm that manages funds and accounts with commitments totalling ~€5.5 billion across four investment strategies. In addition, A&M Capital maintains a strategic association with Alvarez & Marsal, one of the world’s largest growth and operationally focused advisory firms. For additional information, please visit A&M Capital Europe’s website at www.a-mcapital.com.

GBUKGroupICON

A&M Capital Europe Announces Majority Investment in GBUK Group

A&M Capital Europe Announces Majority Investment in GBUK Group 344 344 Nick.Welbourn@gbukgroup.com

A&M Capital Europe Announces Majority Investment in GBUK Group

January 9, 2024 – A&M Capital Europe (“AMCE”), a London-based middle-market private equity investment firm with €650 million of assets under management, announces the acquisition of a majority stake in GBUK Group (the “Company”), a leading global provider of specialist single-use medical devices, from H2 Equity Partners (“H2EP”).

Headquartered in the United Kingdom, GBUK designs, develops and distributes a comprehensive portfolio of own and third-party branded acute-setting medical devices across enteral feeding, vascular access, patient handling and the broader critical care environment. The Company is a top 20 supplier to the UK National Health Service (“NHS”) and supports healthcare professionals and patients in over 45 countries with more than 600,000 medical devices daily. GBUK has demonstrated a track record of penetrating new care areas by leveraging its R&D capabilities and a high-touch sales model hinging on wrap-around services.

The partnership with AMCE is expected to enable GBUK to enhance patient care further and drive the innovation required to support the evolving needs of patients and healthcare providers. Leveraging GBUK’s intimate understanding of patient needs, new product development expertise and global supply-chain capabilities, the Company is well-positioned to continue delivering on this mission and support patients globally.

Additionally, with AMCE’s support, GBUK intends to pursue bolt-on acquisitions, focusing primarily on proprietary medical device specialists in the United Kingdom and broader European and North American markets.

GBUK will continue under the leadership of its existing management team, led by CEO Mike Geering, with Mike and his team investing alongside AMCE.

AMCE was advised by Weil, Gotshal & Manges as legal adviser, Houlihan Lokey as financial adviser, MDW Capital Partners as debt adviser, Boston Consulting Group as commercial adviser, Alvarez & Marsal as accounting and operational adviser, and EY as tax adviser.

About A&M Capital Europe

AMCE is a London-headquartered, middle-market private equity investment firm specialising in building pan-European platform companies through buy-and-build in the middle market. AMCE Fund I currently has €650 million of assets under management, and GBUK represents AMCE’s seventeenth transaction. More broadly, AMCE is part of A&M Capital, a multi-strategy private equity investment firm with ~€4.8 billion in assets under management across four investment strategies. In addition, A&M Capital maintains a strategic association with Alvarez & Marsal, one of the world’s largest operationally focused advisory firms. For additional information, please visit A&M Capital Europe’s website at www.a-mcapital.com.

GBUK Global Icon

We’re incredibly excited to announce the launch of our new International Division…

We’re incredibly excited to announce the launch of our new International Division… 344 345 Nick.Welbourn@gbukgroup.com

We’re incredibly excited to announce the launch of our new International Division…

GBUK Global Logo

Who is GBUK Global?

GBUK Global partners internationally with ambitious companies that share our passion for Enhancing Patient Care within Enteral Feeding, Surgical & Critical Care, Vascular Access and Patient Handling.
With our market leading medical devices, along with our patient and end user solution focused philosophy, we can provide our customers and distribution partners with an industry leading go‑to market strategy, helping to enable their ambitions for future growth and success for years to come.

How will this change affect our customers and distribution partners?

Short answer: it won’t!

There won’t be any change to the high standard of communication from the team, or the quality of our products. Customers and distribution partners will still place orders the same way they always have.

At GBUK Global we value your feedback

We are committed to providing you with the best possible experience. If you have any questions, comments, or concerns, please do not hesitate to contact us.

Our customer service team is available to assist you with any inquiries you may have. You can reach us via phone, email, or by filling out the contact form. We appreciate your business and look forward to hearing from you!

Call us

+44 (0)1757 288 587
Lines open
8:30 am to 5:30 pm
Monday - Friday

Deliveries

For all deliveries and collections, please park in the designated bay (HGV6) and call our number to confirm that you are in the HGV bay.

Visit us

GBUK Group Ltd.
Woodland House,
Blackwood Hall Business Park,
North Duffield,
Selby,
North Yorkshire,
YO8 5DD,
United Kingdom

Get in touch!

    AutoFuser

    Pain Management

    Pain Management 2080 1936 Nick.Welbourn@gbukgroup.com

    Strategies for Coping with Chronic Pain

    Pain is a common experience that can be caused by a variety of factors, including injury, illness, or chronic conditions. read more

    Maggie Williams Award

    Maggie Williams Award Winner

    Maggie Williams Award Winner 1500 1335 Nick.Welbourn@gbukgroup.com

    MAGGIE WILLIAMS AWARD WINNER LEE QUICKMIRE HEAD OF GROUP MARKETING & BANANA DEVELOPMENT AT GBUK GROUP.

    THE NOMINATION Lee has been involved in patient handling for 15 years and is one of the most enthusiastic people one could meet within the sector. He comes up with innovative products to make life easier for staff and enhance the quality of care that we can provide patients. He was recently involved in designing a product for a woman who couldn’t be moved and handled and was in a lot of pain when others were trying to move her. He truly cares about patient care and improving the standards that we set. He drove seven hours to assist moving a 63 stone man. He is well known within most health trusts in the UK for his enthusiasm and commitment to making patient care better and won’t stop until he can achieve this. With every product that he designs. it is always with the intention of making things better. He listens to the problem and comes up with a solution. There is no-one more deserving of this award and he has dedicated his career to making care better.

    BlueBox-600

    GBUK Group is excited to announce the acquisition of Bluebox Medical

    GBUK Group is excited to announce the acquisition of Bluebox Medical 600 600 Nick.Welbourn@gbukgroup.com

    GBUK Group is excited to announce the acquisition of Bluebox Medical, a UK based medical device distribution company.

    The strong portfolio of products including Grip-Lok® Fixation Devices, AutoFuser® Patient Controlled Analgesia range and InfuseIT Pressure Infusion Bags, compliment the existing GBUK offering to the NHS, and will be proudly supported by the business going forward and by our specialist sales team in the Healthcare and Enteral divisions.

    RCN-600

    Vascular Access eLearning is now RCN accredited

    Vascular Access eLearning is now RCN accredited 600 600 Nick.Welbourn@gbukgroup.com

    GBUK Healthcare are delighted to receive accreditation from The Royal College of Nursing for our IV E-Learning module. The RCN Accreditation is the seal of approval for healthcare training, with all accredited programmes subjected to a rigorous quality assessment ensuring they meet the RCN’s standard of excellence.

    vaccinationsyringesneedles-mobile

    CV Vaccination Syringes & Needles

    CV Vaccination Syringes & Needles 450 454 Nick.Welbourn@gbukgroup.com

    GBUK Group are very proud to have provided syringes & needles to the NHS to be used as the delivery system for the CV-19 vaccine. Our team of experts are here to offer any support required to clinicians around the country. Please contact us for any support you require.

    GBUK Group has collaborated with a long-term manufacturing partner to prepare these devices for the Global market, who have made and supplied millions of products to us in the past.

    For any enquiries regarding these products please contact info@gbukgroup.com